Gemcitabine alters the proteasome composition and immunopeptidome of tumour cells

A. M. Gravett, A. M. Gravett, S. Stevanović, S. Stevanović, A. G. Dalgleish, A. G. Dalgleish, J. Copier, J. Copier
  • OncoImmunology, February 2018, Taylor & Francis
  • DOI: 10.1080/2162402x.2018.1438107

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

Read Publication

http://dx.doi.org/10.1080/2162402x.2018.1438107

The following have contributed to this page: prof angus g dalgleish